Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-08

Clinical Trial Update: Meclizine as a Potential Smoking Cessation Treatment [Phase 2]

View source ↗

Summary

Phase 2 study evaluating meclizine as a potential treatment for smoking cessation has completed and posted results in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Meclizine (meclizine)

Snippet

Sponsor: Duke University | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2014-05-08